Application
B4GALNT1 Antibody (Center) western blot analysis in mouse Neuro-2a cell line lysates (35ug/lane).This demonstrates the B4GALNT1 Antibody detected the B4GALNT1 protein (arrow).Application
B4GALNT1 Antibody (Center) western blot analysis in MDA-MB453 cell line lysates (35ug/lane).This demonstrates the B4GALNT1 antibody detected the B4GALNT1 protein (arrow).| Product Name | B4GALNT1 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | GALGT, SIAT2 |
|---|---|
| Alternative Names | B4GALNT1 GALGT SIAT2 Beta-1 4 N-acetylgalactosaminyltransferase 1 (N-acetylneuraminyl)-galactosylglucosylceramide GM2/GD2 synthase GalNAc-T |
| Molecular Weight(MW) | 58882 Da |
| Function | Involved in the biosynthesis of gangliosides GM2, GD2 and GA2 |
| Tissue Specificity | This B4GALNT1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 295-323 amino acids from the Central region of human B4GALNT1. |
| Cellular Localization | Golgi apparatus membrane; Single-pass type II membrane protein |
| Entrez Gene | 2583 |
|---|---|
| Nucleotide Accession | NP_001469.1 |
Application
B4GALNT1 Antibody (Center) western blot analysis in mouse Neuro-2a cell line lysates (35ug/lane).This demonstrates the B4GALNT1 Antibody detected the B4GALNT1 protein (arrow).
Application
B4GALNT1 Antibody (Center) western blot analysis in MDA-MB453 cell line lysates (35ug/lane).This demonstrates the B4GALNT1 antibody detected the B4GALNT1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
